Lijing Wang Selected Research

Glipizide (Glucotrol)

1/2022	Glipizide Combined with ANP Suppresses Breast Cancer Growth and Metastasis by Inhibiting Angiogenesis through VEGF/VEGFR2 Signaling.
1/2016	Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis.
5/2015	Glipizide suppresses embryonic vasculogenesis and angiogenesis through targeting natriuretic peptide receptor A.
10/2014	Glipizide, an antidiabetic drug, suppresses tumor growth and metastasis by inhibiting angiogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lijing Wang Research Topics

Disease

49	Neoplasms (Cancer) 05/2022 - 05/2008
16	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2012
12	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2017
7	Inflammation (Inflammations) 09/2021 - 09/2015
6	Stomach Neoplasms (Stomach Cancer) 01/2022 - 07/2017
6	Carcinoma (Carcinomatosis) 01/2022 - 01/2015
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2014
5	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 01/2020
5	Carcinogenesis 01/2019 - 01/2015
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 03/2020
4	Cognitive Dysfunction 01/2022 - 01/2021
4	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 01/2017
4	Lung Neoplasms (Lung Cancer) 10/2020 - 07/2014
4	Endometrial Neoplasms (Endometrial Cancer) 01/2019 - 01/2012
4	Atherosclerosis 01/2018 - 12/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 04/2014
3	Infections 10/2021 - 11/2019
3	Periodontitis 01/2021 - 01/2020
3	Fibrosis (Cirrhosis) 01/2021 - 12/2015
3	Diabetic Nephropathies (Diabetic Nephropathy) 12/2016 - 12/2011
2	Melanoma (Melanoma, Malignant) 04/2022 - 01/2018
2	COVID-19 12/2021 - 01/2020
2	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 01/2021
2	Ischemic Stroke 01/2021 - 01/2020
2	Hyperplasia 02/2020 - 01/2012
2	Lymphatic Metastasis 12/2018 - 01/2012
2	Triple Negative Breast Neoplasms 10/2018 - 01/2017
2	Lymphoma (Lymphomas) 03/2018 - 08/2016
2	Hypertrophy 12/2016 - 03/2014
2	Atherosclerotic Plaque (Atheroma) 01/2016 - 12/2014
2	Disease Progression 01/2015 - 01/2012
2	Hepatocellular Carcinoma (Hepatoma) 06/2012 - 06/2012
2	Mucoepidermoid Carcinoma 01/2012 - 03/2002
1	Squamous Cell Carcinoma of Head and Neck 05/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2012
11	Pharmaceutical PreparationsIBA 04/2022 - 10/2014
8	Messenger RNA (mRNA)IBA 01/2022 - 07/2014
7	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2013
6	CholesterolIBA 04/2022 - 09/2015
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2013
5	Biological ProductsIBA 04/2022 - 01/2019
5	P-SelectinIBA 01/2017 - 01/2015
4	Biomarkers (Surrogate Marker)IBA 05/2022 - 12/2014
4	Alanine (L-Alanine)FDA Link 01/2022 - 04/2013
4	Glipizide (Glucotrol)FDA LinkGeneric 01/2022 - 10/2014
4	Taurine FDA Link 01/2022 - 04/2013
4	andrographolideIBA 01/2021 - 11/2013
4	Choline (Choline Chloride)IBA 01/2018 - 04/2013
3	OxysterolsIBA 04/2022 - 01/2021
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2015
3	Glutamic Acid (Glutamate)FDA Link 01/2022 - 04/2013
3	Valine (L-Valine)FDA Link 01/2022 - 12/2014
3	Methionine (L-Methionine)FDA Link 01/2022 - 12/2014
3	Citric Acid (Citrate)FDA LinkGeneric 01/2022 - 01/2015
3	Oxygen (Dioxygen)IBA 01/2021 - 01/2017
3	Anaplastic Lymphoma KinaseIBA 10/2020 - 03/2018
3	CateninsIBA 09/2020 - 01/2019
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 12/2017
3	Small Interfering RNA (siRNA)IBA 01/2019 - 07/2014
3	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2018 - 12/2014
3	Apolipoproteins E (ApoE)IBA 01/2016 - 12/2014
2	Matrix Metalloproteinases (MMPs)IBA 05/2022 - 02/2015
2	27-hydroxycholesterolIBA 04/2022 - 01/2022
2	Inositol (Myoinositol)IBA 01/2022 - 04/2013
2	Aspartic Acid (Aspartate)FDA Link 01/2022 - 08/2016
2	LipidsIBA 01/2022 - 12/2021
2	Glutamine (L-Glutamine)FDA Link 01/2022 - 01/2018
2	Leucine (L-Leucine)FDA Link 01/2022 - 08/2016
2	CreatineIBA 01/2022 - 04/2013
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2018
2	Pyruvic Acid (Pyruvate)IBA 01/2022 - 01/2018
2	InflammasomesIBA 09/2021 - 08/2020
2	SmokeIBA 09/2021 - 07/2021
2	LipopolysaccharidesIBA 09/2021 - 01/2021
2	Triggering Receptor Expressed on Myeloid Cells-1IBA 09/2021 - 07/2021
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 12/2016
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 10/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 06/2015
2	Phenobarbital (Luminal)FDA Link 01/2021 - 01/2017
2	LigandsIBA 01/2021 - 01/2019
2	2,3- dimethoxy- 5- methyl- 6- decyl- 1,4- benzoquinoneIBA 01/2021 - 01/2020
2	coenzyme Q10 (CoQ10)IBA 01/2021 - 01/2020
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2020 - 03/2018
2	Indicators and Reagents (Reagents)IBA 02/2020 - 01/2018
2	Histones (Histone)IBA 01/2020 - 01/2017
2	hepatoma-derived growth factorIBA 01/2019 - 01/2014
2	dipalmitoylphosphatidic acidIBA 10/2018 - 01/2017
2	Acetates (Acetic Acid Esters)FDA Link 01/2018 - 01/2015
2	Amyloid (Amyloid Fibrils)IBA 01/2016 - 06/2015
2	CollagenIBA 01/2016 - 12/2015
2	Amino Acids FDA Link 01/2015 - 12/2014
2	Fibronectins (Fibronectin)IBA 11/2013 - 12/2011
1	LuteolinIBA 04/2022
1	24-hydroxycholesterolIBA 04/2022

Therapy/Procedure

10	Therapeutics 01/2022 - 05/2008
3	Intraperitoneal Injections 01/2021 - 04/2015
3	Ligation 01/2021 - 02/2015
3	Drug Therapy (Chemotherapy) 01/2020 - 01/2018
2	Transplantation 01/2022 - 04/2015